EMA: Q&As on the Topic of "Parallel Distribution" updated
Recommendation
28/29 April 2026
From QbD to Process Validation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
Again, the "Frequently asked questions about parallel distribution" were revised and published on the EMA website. The information provided by the EMA on parallel distribution of centrally authorised medicinal products is set out in the Q&A in six paragraphs:
- General
- Initial notification
- Parallel distribution notification check
- Post - Parallel distribution notice guidance
- Safety updates/bulk changes/annual update
- Fees
In the latest version, the following question has been added to the first section "General":
- 07. What to do when my organisation details have changed?
In the fifth paragraph "Safety updates/bulk changes/annual update", questions 4 and 5 and their answers have been updated:
- 04. How to submit a bulk change?
- 05. What is an annual update?
The four other sections remain unchanged.
The updates and the complete list of answers to the "Frequently asked questions about parallel distribution" can be found on the EMA website.
Related GMP News
18.03.2026ICH M4Q(R2): List of comments published
11.03.2026ASMF: CMDh updates Information on "Worksharing Procedure"
04.03.2026CMDh: Update of Q&As for Generic Drug Submissions
18.02.2026HMA/CMDh: Update to the Best Practice Guides on Variations
11.02.2026Q&As for Centralized Procedures - further Update
04.02.2026EMA: IRIS Document revised